绝经后-话题@MedSci

#绝经后#

217篇内容 | 4135人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1631615, encodeId=d2d91631615e2, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=Eur Heart J：体重指数正常的绝经后妇女区域体脂与心血管疾病风险的关系, objectType=article, longId=174664, objectId=cb801e4664b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb801e4664b1, replyNumber=0, likeNumber=66, createdTime=2019-07-03, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb801e4664b1, moduleTitle=Eur Heart J：体重指数正常的绝经后妇女区域体脂与心血管疾病风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb801e4664b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631614, encodeId=d3a216316142f, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=BJOG：绝经后出血的诊断检查：随机对照试验, objectType=article, longId=168461, objectId=238b1684618a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=238b1684618a, replyNumber=0, likeNumber=100, createdTime=2019-06-16, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=238b1684618a, moduleTitle=BJOG：绝经后出血的诊断检查：随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=238b1684618a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631613, encodeId=656a16316131a, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=仑伐替尼联合来曲唑在绝经后HR+局部晚期/转移性乳腺癌中的探索, objectType=article, longId=166861, objectId=f28a1668612c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28a1668612c, replyNumber=0, likeNumber=63, createdTime=2019-05-28, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28a1668612c, moduleTitle=仑伐替尼联合来曲唑在绝经后HR+局部晚期/转移性乳腺癌中的探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28a1668612c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631612, encodeId=378e163161284, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=JCLA：绝经后梅尼埃病患者听觉前庭功能与雌激素水平的关系, objectType=article, longId=166240, objectId=c15816624076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c15816624076, replyNumber=0, likeNumber=78, createdTime=2019-05-18, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c15816624076, moduleTitle=JCLA：绝经后梅尼埃病患者听觉前庭功能与雌激素水平的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c15816624076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631611, encodeId=514b1631611b3, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=BioSyent宣布加拿大卫生部批准替勃龙，用于治疗绝经后妇女的血管舒缩, objectType=article, longId=166109, objectId=00b81661090d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00b81661090d, replyNumber=0, likeNumber=59, createdTime=2019-05-16, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00b81661090d, moduleTitle=BioSyent宣布加拿大卫生部批准替勃龙，用于治疗绝经后妇女的血管舒缩, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00b81661090d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631610, encodeId=3c5c163161003, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗, objectType=article, longId=164262, objectId=5e1516426299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e1516426299, replyNumber=0, likeNumber=28, createdTime=2019-04-15, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e1516426299, moduleTitle=2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e1516426299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631609, encodeId=7ea51631609d5, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=BMJ：女性绝经后使用激素治疗阿尔兹海默症的风险分析, objectType=article, longId=164238, objectId=d7171642389c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7171642389c, replyNumber=0, likeNumber=46, createdTime=2019-04-15, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7171642389c, moduleTitle=BMJ：女性绝经后使用激素治疗阿尔兹海默症的风险分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7171642389c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631608, encodeId=0c9d16316080b, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=安进/优时比的抗骨硬化蛋白单抗romosozumab，获FDA批准治疗绝经后妇女的骨质疏松症, objectType=article, longId=164049, objectId=df2216404974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2216404974, replyNumber=0, likeNumber=70, createdTime=2019-04-12, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2216404974, moduleTitle=安进/优时比的抗骨硬化蛋白单抗romosozumab，获FDA批准治疗绝经后妇女的骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2216404974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631607, encodeId=6449163160e60, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=针对绝经后骨质疏松症治疗的新指南, objectType=article, longId=163093, objectId=547c163093e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=547c163093e3, replyNumber=0, likeNumber=62, createdTime=2019-03-29, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=547c163093e3, moduleTitle=针对绝经后骨质疏松症治疗的新指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=547c163093e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631606, encodeId=0e301631606f3, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=Gastroenterology：艾美拉唑和右兰索拉唑不会影响健康绝经后女性骨稳态, objectType=article, longId=162291, objectId=e9e416229189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9e416229189, replyNumber=0, likeNumber=60, createdTime=2019-03-15, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9e416229189, moduleTitle=Gastroenterology：艾美拉唑和右兰索拉唑不会影响健康绝经后女性骨稳态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9e416229189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631605, encodeId=f8ba16316052b, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=BMJ：绝经后激素治疗与阿尔茨海默病的风险, objectType=article, longId=161877, objectId=2c331618e73c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c331618e73c, replyNumber=0, likeNumber=74, createdTime=2019-03-09, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c331618e73c, moduleTitle=BMJ：绝经后激素治疗与阿尔茨海默病的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c331618e73c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631604, encodeId=3573163160499, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=JAHA：绝经后妇女25-羟基维生素D和甲状旁腺激素水平的种族差异和心血管疾病风险, objectType=article, longId=160382, objectId=3c4d16038232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c4d16038232, replyNumber=0, likeNumber=0, createdTime=2019-02-20, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c4d16038232, moduleTitle=JAHA：绝经后妇女25-羟基维生素D和甲状旁腺激素水平的种族差异和心血管疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c4d16038232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631603, encodeId=36e716316032c, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=J Clin Endocrinol Metab：特立帕肽治疗对骨质疏松症绝经后妇女循环骨膜素的影响及其与骨形成和骨密度调节因子的关系, objectType=article, longId=160252, objectId=59fc160252db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59fc160252db, replyNumber=0, likeNumber=77, createdTime=2019-02-18, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59fc160252db, moduleTitle=J Clin Endocrinol Metab：特立帕肽治疗对骨质疏松症绝经后妇女循环骨膜素的影响及其与骨形成和骨密度调节因子的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59fc160252db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631602, encodeId=70b8163160230, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=2018 ACR适宜性标准：绝经后亚急性或慢性盆腔疼痛, objectType=article, longId=159386, objectId=7702159386d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7702159386d7, replyNumber=0, likeNumber=29, createdTime=2019-02-03, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7702159386d7, moduleTitle=2018 ACR适宜性标准：绝经后亚急性或慢性盆腔疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7702159386d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631601, encodeId=193e16316018f, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=Med Sci Monit：间歇性甲状旁腺激素1-34给药对绝经后骨质疏松妇女循环间充质干细胞的影响, objectType=article, longId=158997, objectId=243e15899e2b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=243e15899e2b, replyNumber=0, likeNumber=55, createdTime=2019-01-28, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=243e15899e2b, moduleTitle=Med Sci Monit：间歇性甲状旁腺激素1-34给药对绝经后骨质疏松妇女循环间充质干细胞的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=243e15899e2b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631600, encodeId=9d8b16316005f, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=Biochem Biophys Res Commun：Let-7a-5p抑制绝经后骨质疏松症小鼠的骨髓间充质干细胞成骨, objectType=article, longId=158930, objectId=3c3715893033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c3715893033, replyNumber=0, likeNumber=70, createdTime=2019-01-27, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c3715893033, moduleTitle=Biochem Biophys Res Commun：Let-7a-5p抑制绝经后骨质疏松症小鼠的骨髓间充质干细胞成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c3715893033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631599, encodeId=8717163159972, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=PLOS ONE：绝经后雌激素治疗对焦虑和抑郁的影响, objectType=article, longId=157068, objectId=e94c15e068ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e94c15e068ec, replyNumber=0, likeNumber=0, createdTime=2019-01-01, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e94c15e068ec, moduleTitle=PLOS ONE：绝经后雌激素治疗对焦虑和抑郁的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e94c15e068ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631598, encodeId=ec29163159890, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=J Natl Cancer Inst：塞来昔布联用阿司匹林是绝经后激素受体阳性乳腺癌患者的福音？, objectType=article, longId=151815, objectId=b9ac151815da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9ac151815da, replyNumber=0, likeNumber=63, createdTime=2018-10-26, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9ac151815da, moduleTitle=J Natl Cancer Inst：塞来昔布联用阿司匹林是绝经后激素受体阳性乳腺癌患者的福音？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9ac151815da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631597, encodeId=8121163159efb, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=Front Physiol：绝经后牙周炎进展的不同机制, objectType=article, longId=151168, objectId=39c11511684f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39c11511684f, replyNumber=0, likeNumber=46, createdTime=2018-10-18, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39c11511684f, moduleTitle=Front Physiol：绝经后牙周炎进展的不同机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39c11511684f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1631596, encodeId=6f4a1631596c2, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子, objectType=article, longId=150549, objectId=dbad1505497d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbad1505497d, replyNumber=0, likeNumber=27, createdTime=2018-10-09, rootId=0, userName=zxxiang, userId=32b921798518, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbad1505497d, moduleTitle=Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbad1505497d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

绝经后

2020-05-29

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

Eur Heart J：体重指数正常的绝经后妇女区域体脂与心血管疾病风险的关系

2019-07-03

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

BJOG：绝经后出血的诊断检查：随机对照试验

2019-06-16

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

仑伐替尼联合来曲唑在绝经后HR+局部晚期/转移性乳腺癌中的探索

2019-05-28

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

JCLA：绝经后梅尼埃病患者听觉前庭功能与雌激素水平的关系

2019-05-18

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

BioSyent宣布加拿大卫生部批准替勃龙，用于治疗绝经后妇女的血管舒缩

2019-05-16

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗

2019-04-15

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

BMJ：女性绝经后使用激素治疗阿尔兹海默症的风险分析

2019-04-15

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

安进/优时比的抗骨硬化蛋白单抗romosozumab，获FDA批准治疗绝经后妇女的骨质疏松症

2019-04-12

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

针对绝经后骨质疏松症治疗的新指南

2019-03-29

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

Gastroenterology：艾美拉唑和右兰索拉唑不会影响健康绝经后女性骨稳态

2019-03-15

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

BMJ：绝经后激素治疗与阿尔茨海默病的风险

2019-03-09

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

JAHA：绝经后妇女25-羟基维生素D和甲状旁腺激素水平的种族差异和心血管疾病风险

2019-02-20

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

J Clin Endocrinol Metab：特立帕肽治疗对骨质疏松症绝经后妇女循环骨膜素的影响及其与骨形成和骨密度调节因子的关系

2019-02-18

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

2018 ACR适宜性标准：绝经后亚急性或慢性盆腔疼痛

2019-02-03

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

Med Sci Monit：间歇性甲状旁腺激素1-34给药对绝经后骨质疏松妇女循环间充质干细胞的影响

2019-01-28

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

Biochem Biophys Res Commun：Let-7a-5p抑制绝经后骨质疏松症小鼠的骨髓间充质干细胞成骨

2019-01-27

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

PLOS ONE：绝经后雌激素治疗对焦虑和抑郁的影响

2019-01-01

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

J Natl Cancer Inst：塞来昔布联用阿司匹林是绝经后激素受体阳性乳腺癌患者的福音？

2018-10-26

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

Front Physiol：绝经后牙周炎进展的不同机制

2018-10-18

zxxiang (审核中...)

前往app查看评论内容

#绝经后#

Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子

2018-10-09

科室
- - 订阅+
  - 更多科室
工具
服务